A thousand words about microparticles in cardiology
DOI:
https://doi.org/10.20883/medical.e67Keywords:
laboratory diagnostics, extracellular microvesicles, endothelial dysfunction, platelet activationAbstract
Microparticles (MPs) are membrane vesicles of 0.1–1 µm in diameter produced mainly by platelets, vascular endothelium and blood cells in response to cell activation and stress factors. MPs can be also released during malignant transformation or apoptosis. The essential step in MP formation is the loss of the cell membrane asymmetric phospholipid distribution as response to the increased intracellular calcium levels. MPs contain, proteins and genetic material (DNA, miRNA, mRNA) which enables them to interact and influence target cell. MPs are considered to be markers of ongoing pathophysiological processes in cardiovascular system, due to their role in inflammation and coagulation.Downloads
References
Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res. 2010;107(9):1047–57.
Tushuizen ME, Diamant M, Sturk A, Nieuwland R. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe? Arterioscler Thromb Vasc Biol. 2011;31(1):4–9.
Morel O, Morel N, Jesel L, Freyssinet JM, Toti F. Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis. Semin Immunopathol. 2011;33(5):469–86.
Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569–79.
Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipids asymmetry. Blood. 1997;89(4):1121–32.
Trams EG, Lauter CJ, Salem N Jr, Heine U. Exfoliation of membrane ectoenzymes in the form of microvesicles. Biochim Biophys Acta. 1981;645(1):63–70.
Stępień E, Targosz-Korecka M. Microparticles in endothelial function. Post Bioch. 2013;59(4):395–403.
Mastronardi ML, Mostefai HA, Meziani F, Martínez MC, Asfar P, Andriantsitohaina R. Circulating microparticles from septic shock patients exert differential tissue expression of enzymes related to inflammation and oxidative stress. Crit Care Med. 2011;39(7):1739–48.
Sekuła M, Janawa G, Stankiewicz E, Stępień E. Endothelial microparticle formation in moderate concentrations of homocysteine and methionine in vitro. Cell Mol Biol Lett. 2011;16(1):69–78.
Helal O, Defoort C, Robert S, Marin C, Lesavre N, Lopez- -Miranda J, et al. Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress. Nutr Metab Cardiovasc Dis. 2011;21(9):665–71.
Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One. 2008;3(11):e3694.
Issekutz TB, Issekutz AC, Movat HZ. The in vivo quantitation and kinetics of monocyte migration into acute inflammatory tissue. Am J Pathol. 1981;103(1):47–55.
Boulanger CM, Amabile N, Tedgui A. Circulating microparticles – A potential prognostic marker for atherosclerotic vascular disease. Hypertension. 2006;48(2):180–6.
Barry OP, Pratico D, Savani RC, Fitzgerald GA. Modulation of monocyte- endothelial cell interactions by platelet microparticles. J Clin Invest. 1998;102(1):136–44.
Mesri M, Altieri DC. Endothelial cell activation by leukocyte microparticles. J Immunol. 1998;161(8):4382–7.
Muller I, Klocke A, Alex M, Kotzsch M, Luther T. Morgenstern E, et al. Intravascular tissue factor initiates coagulation via circulating microparticles and platelets. FASEB J. 2003;17(3):476–8.
Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation. 2001;104(22):2649–52.
Chirinos JA, Heresi GA, Velasquez H, Jy W, Jimenez JJ, Ahn E, et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol. 2005;45(9): 1467–71.
Stępień E, Stankiewicz E, Zalewski J, Godlewski J, Zmudka K, Wybrańska I. Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation. Arch Med Res. 2012;43(1):31–5.
Williams JB, Jauch EC, Lindsell CJ, Campos B. Endothelial microparticle levels are similar in acute ischemic stroke and stroke mimics due to activation and not apoptosis/necrosis. Acad Emerg Med. 2007;14(8):685–90.
Ogata N, Nomura S, Shouzu A, Imaizumi M, Arichi M, Matsumura M. Elevation of monocyte-derived microparticles in patients with diabetic retinopathy. Diabetes Res Clin Pract. 2006;73(3):241–8.
Stępień E, Kabłak-Ziembicka A, Czyż J, Przewłocki T, Małecki M. Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging. Expert Opin Ther Targets. 2012;16(7):677–88.
Preston RA, Jy W, Jimenez JJ, Mauro LM, Horstman LL, Valle M, Aime G, Ahn YS. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension. 2003;41(2):211–7.
Koga H, Sugiyama S, Kugiyama K, Watanabe K, Fukushima H, Tanaka T, et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol. 2005;45(10):1622–30.
Burger D, Touyz RM. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. J Am Soc Hypertens. 2012;6(2):85–99.
Downloads
Published
Issue
Section
License
Copyright (c) 2014 Magda Konkolewska, Szczepan Kurc, Ewa Stępień
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
